Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial

This is an open-label, randomized, controlled, phase 3 trial done at 29 hospitals in China. Patients had pathologically confirmed HER2-positive metast...

The impact of the COVID-19 pandemic on radiotherapy services in England, UK: a population-based study

In 2020, mean weekly radiotherapy courses fell by 19% in April, 6% in May, and 11% in June compared with corresponding months in 2019. The largest red...

Departments

Recent Posts